<< Back New York biotech company takes massive loss in selloff of CBD unit 39 0 System Admin / Thursday, December 7, 2023 / Categories: HempToday.net New York-based 22nd Century Group said it intends to sell off its GVB Biopharma unit, a CBD maker, with the price tag estimated at $2.25 million – after having purchased … New York biotech company takes massive loss in selloff of CBD unit Read More » Print 0Upvote 0Downvote Tags CBDInvestmentNewsNorth AmericaUSACompaniesTransactions Related articles South Carolina bans CBD and intoxicating hemp products as states continue crackdowns German hemp company says it will diversify into vape device sales Hempcrete seen as part of eco-friendly solution to Zimbabwe’s housing shortage Ahead for the industry: Fiber and food, sure, but hemp will be relegated to a ‘specialty crop’ U.S. CBD company inks sponsorship deal with professional baseball league << Back
